Ligand validation:6PP2

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PP2_BTB_B_504	56%	59%	0.131	0.902	0.57	0.98	-	-	2	0	100%	1
6PP2_BTB_C_504	37%	9%	0.213	0.913	2.98	1.47	1	2	4	0	100%	1
6PP2_BTB_D_504	32%	62%	0.179	0.853	0.38	1.06	-	1	7	0	100%	1
6PP2_BTB_A_504	31%	1%	0.235	0.907	5.16	2.52	3	2	6	0	100%	1
6PP2_BTB_C_505	24%	36%	0.181	0.812	1.1	1.41	2	2	0	0	100%	1
6PP2_BTB_A_505	22%	64%	0.175	0.792	0.55	0.81	-	-	2	0	100%	1
6PP2_BTB_D_506	19%	77%	0.19	0.782	0.42	0.51	-	-	5	0	100%	1
6PP2_BTB_D_505	14%	32%	0.218	0.766	0.9	1.79	1	3	10	0	100%	1
6PP2_BTB_B_506	12%	49%	0.172	0.704	0.66	1.29	-	1	7	0	100%	1
6PP2_BTB_B_505	11%	65%	0.188	0.701	0.59	0.74	-	-	2	0	100%	1
6PP2_BTB_C_506	2%	78%	0.203	0.471	0.35	0.54	-	-	1	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
9CW9_BTB_D_504	100%	70%	0.036	0.994	0.39	0.76	-	-	1	0	100%	1
5UOB_BTB_B_504	100%	73%	0.038	0.994	0.58	0.47	-	-	3	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.